Home People Search Help Community Market Magazine Chat News More
Magazine
Browse Alphabetically
Search News
 
Latest Featured News
Ever think about why people keep buying iPhones, even though they're so darned pricey?
9 days ago · From admin
Recent News
Developers offer a slew of medication adherence platforms that, along with human intervention, help people take their medications correctly.
16 minutes ago · From admin
The land where Scotch whisky was born has introduced a long-debated public health initiative‚ÄĒdiscouraging problem drinking by setting minimum prices for booze.
16 minutes ago · From admin
Drugmakers have worked hard to blame the 340B program for skyrocketing drug prices, but no amount of misdirection can overcome mounting evidence that drug prices are the root of the problem, Dr. Bruce Siegel says.
16 minutes ago · From admin
HonorHealth saved $1.5 million when it renegotiated prices for knee and hip implants. Hospitals nationwide are looking for ways to eliminate cost variation in this service line.
16 minutes ago · From admin
The Association of American Medical Colleges has been lobbying Congress to find ways to address what's expected to be a devastating physician shortage. AAMC CEO Dr. Darrell Kirch spoke to Modern Healthcare about issues facing the next generation of physicians.
16 minutes ago · From admin
James Harrison donated plasma almost every week for the last 60 years and helped save 2.4 million babies.
16 minutes ago · From admin
Drug shortages continue to keep providers across the nation scrambling to find options for patient care. A new survey from the American College of Emergency Physicians found that 9 in 10 doctors are taking time away from patients as they search for alternative therapies.
16 minutes ago · From admin
Source: http://www.modernhealthcare.com/article/20180526/MAGAZINE/305269989
16 minutes ago · From admin
Public health advocates say the battles over opening safe-injection sites for addicts exemplifies how much stigma determines drug policy despite the evidence.
16 minutes ago · From admin
Unless Congress changes the law or the FDA changes guidance on biosimilar development, patients and payers can expect to pay exorbitant prices for biologics long after their patents have expired.
16 minutes ago · From admin